ArticleJournal of the advanced practitioner in oncology2019
Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario.
Kimberly D Allman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.